Table 5.
Variable | Levels | OR (95% CI) | P value |
---|---|---|---|
Age | Q1–median | 0.329 (0.088–1.236) | .0997 |
median–Q3 | 0.593 (0.141–2.501) | .4770 | |
Q3–maximum | 4.840 (0.496. 47.237) | .1749 | |
Race | Thai | 699.320 (20.238–24,164.24) | .0003 |
White | 35.633 (2.428–522.860) | .0091 | |
Korean | 17.198 (1.201–246.334) | .0362 | |
Other | — | — | |
PEDT | 0.782 (0.244–2.512) | .680 | |
IELT | 3.934 (1.024–15.113) | .461 | |
AE | 0.312 (0.080–1.213) | .0927 | |
Dosage group | 30 → 60 → 60 mg | 1.483 (0.407–5.405) | .5500 |
30 → 60 → 30 mg | 0.318 (0.057–1.767) | .1906 |
AE = adverse event; IELT = intravaginal ejaculation latency time; OR = odds ratio; PEDT = Premature Ejaculation Diagnostic Tool; Q = quartile.